We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Feature |  FREE
Arch Surg. 2002;137(1):113-114. doi:.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Original Investigation  | 
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, MD; Igor Vujic, MD; Adil Daud, MD; et al.
JAMA Dermatology
Observation  | 
Cutaneous Vasculopathy as an Adverse Effect of the Anti–Vascular Endothelial Growth Factor Agent Axitinib
Veronica J. Shi, BA; Anjela Galan, MD; Ian D. Odell, MD, PhD; et al.
JAMA Dermatology
Observation  | 
Bullous Pemphigoid Associated With Linagliptin Treatment
Roger Haber, MD; Alice Mouna Fayad, MD; Farid Stephan, MD; et al.
JAMA Dermatology
Observation  | 
Subacute Cutaneous Lupus Erythematosus Induced by Mitotane
Ander Mayor-Ibarguren, MD; María Concepción Roldán-Puchalt, MD; Cristina Gómez-Fernández, MD; et al.